相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer
Roberto Mendez et al.
CARCINOGENESIS (2020)
Modulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated mice
Hongdong Wang et al.
ACTA DIABETOLOGICA (2020)
Exploring the link between diabetes and pancreatic cancer
Margherita Pizzato et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with updates hepatocellular carcinoma
Yi Zheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Nora B. Henrikson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Abnormal gut microbiota composition contributes to the development of type 2 diabetes mellitus in db/db mice
Fan Yu et al.
AGING-US (2019)
Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus
Mateus Kawata Salgaco et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy
I-Ping Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
Sascha Rahn et al.
CANCER LETTERS (2018)
The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study
David M. Golombos et al.
UROLOGY (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells
Loredana Bergandi et al.
FRONTIERS IN PHARMACOLOGY (2018)
The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine
Arthur T. F. Choy et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents
Leore T. Geller et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Patricia Dauer et al.
PANCREATOLOGY (2017)
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor
L. Zeng et al.
ENDOCRINE-RELATED CANCER (2016)
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Alexandra Zhernakova et al.
SCIENCE (2016)
Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells
Alice Nomura et al.
ONCOTARGET (2016)
Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect
G. Ariaans et al.
CANCER TREATMENT REVIEWS (2015)
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
Alice Nomura et al.
ONCOTARGET (2015)
Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis
Yixiang Mao et al.
SCIENTIFIC REPORTS (2015)
CD133+ Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide
Sulagna Banerjee et al.
CLINICAL CANCER RESEARCH (2014)
Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme
Arnulf Mayer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data
Charles E. Robertson et al.
BIOINFORMATICS (2013)
Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study
M. M. J. Zanders et al.
DIABETIC MEDICINE (2013)
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2
K. M. Biernacka et al.
ENDOCRINE-RELATED CANCER (2013)
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Xiuying Zhang et al.
PLOS ONE (2013)
MetAMOS: a modular and open source metagenomic assembly and analysis pipeline
Todd J. Treangen et al.
GENOME BIOLOGY (2013)
Diabetes and pancreatic cancer
Donghui Li
MOLECULAR CARCINOGENESIS (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome
Sahar Abubucker et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity
Antonella Brunello et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Gut microbiota in obesity and metabolic disorders
Yolanda Sanz et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
Vitamin K Prevents Oxidative Cell Death by Inhibiting Activation of 12-Lipoxygenase in Developing Oligodendrocytes
Jianrong Li et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Epidemiology of pancreatic cancer: an overview
Sara Raimondi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding
P. D. Cani et al.
PATHOLOGIE BIOLOGIE (2008)
分享论文
